Crinetics Pharmaceuticals Inc (CRNX) — Net Asset Quality Index
Crinetics Pharmaceuticals Inc (CRNX) has a Net Asset Quality Index of 91.4% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.40 Billion minus total liabilities of $120.68 Million yields net assets of $1.28 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Crinetics Pharmaceuticals Inc (CRNX) liquidity interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Crinetics Pharmaceuticals Inc Net Asset Quality Index Over Time (2016–2025)
This chart shows how Crinetics Pharmaceuticals Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the index stands at 91.4%, representing net assets of $1.28 Billion against total assets of $1.40 Billion USD. Explore CRNX cash flow metrics to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Crinetics Pharmaceuticals Inc (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Crinetics Pharmaceuticals Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CRNX stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.4% | $992.08 Million | $1.14 Billion | $143.41 Million | ▼ -5.0 pp |
| 2024 | 92.3% | $1.32 Billion | $1.43 Billion | $109.79 Million | ▲ +7.5 pp |
| 2023 | 84.9% | $539.11 Million | $635.35 Million | $96.25 Million | ▼ -5.0 pp |
| 2022 | 89.8% | $316.33 Million | $352.18 Million | $35.85 Million | ▼ -4.7 pp |
| 2021 | 94.6% | $331.94 Million | $351.01 Million | $19.07 Million | ▲ +2.5 pp |
| 2020 | 92.1% | $168.92 Million | $183.44 Million | $14.53 Million | ▲ +2.2 pp |
| 2019 | 89.8% | $117.14 Million | $130.38 Million | $13.24 Million | ▼ -3.6 pp |
| 2018 | 93.5% | $160.22 Million | $171.41 Million | $11.19 Million | ▲ +189.8 pp |
| 2017 | -96.3% | $-15.02 Million | $15.60 Million | $30.62 Million | ▼ -47.1 pp |
| 2016 | -49.2% | $-6.20 Million | $12.60 Million | $18.80 Million | — |